Pharmacologic Reduction of CNS Noradrenergic Activity in PTSD: The Case for Clonidine and Prazosin
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
This article reviews the neurobiologic rationale for and presents clinical guidance concerning the use of medications that reduce central nervous system noradrenergic activity in the treatment of intrusive symptoms of posttraumatic stress disorder. The authors reviewed neurobiological studies, nonclinical studies using animal models, clinical case reports, open-label drug studies, and blinded, placebo-controlled drug studies. This review of the basic science and clinical literature, and the authors' clinical experience with culturally and demographically diverse populations, indicate that clonidine and prazosin can play a useful role in treating sleep disturbance and hyperarousal in posttraumatic stress disorder, with minimal adverse effects and low financial cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Corticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
Southwick, S. M., Bremner, J. D., Rasmusson, A., Morgan, C. A., Arnsten, A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00219-x · Cited by 573
CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
Birnbaum, S., Gobeske, K. T., Auerbach, J., Taylor, J. R., & Arnsten, A. F. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00138-9 · Cited by 281
α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function
Arnsten, A. F. T., Mathew, R., Ubriani, R., Taylor, J. R., & Li, B.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00296-0 · Cited by 245
Grillon, C., Morgan, C. A., Southwick, S. M., Davis, M., & Charney, D. S. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02942-3 · Cited by 221
Smajkic, A., Weine, S., Djuric‐Bijedic, Z., Boskailo, E., Lewis, J., & Pavkovic, I. (2001) · Journal of Traumatic Stress · doi:10.1023/a:1011177420069 · Cited by 89
Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine
Ballenger, J. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1216 · Cited by 82
Zimmerman, M., Chelminski, I., & Posternak, M. A. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000110279.23893.82 · Cited by 58
Cited by
Best practice guide for the treatment of nightmare disorder in adults
Standards of Practice Committee, Aurora, R. N., Zak, R. S., Auerbach, S. H., Casey, K. R., Chowdhuri, S., Karippot, A., Maganti, R. K., Ramar, K., Kristo, D. A., et al. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27883 · Cited by 341
Current perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, A. W., Ball, S. G., Martinez, J., Robinson, M. J., Yang, C. R., Russell, J. M., & Shekhar, A. (2010) · Depression and Anxiety · doi:10.1002/da.20642 · Cited by 316
Zoladz, P. R., & Diamond, D. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.024 · Cited by 305
Treatment of Nightmares With Prazosin: A Systematic Review
Kung, S., Espinel, Z., & Lapid, M. I. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.05.015 · Cited by 277
Kennedy, J. E. (2007) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2006.12.0166 · Cited by 261
Metadata
- Authors
- BOEHNLEIN, J. K., & KINZIE, J. D.
- Venue
- Journal of Psychiatric Practice
- Published
- 2007-03
- Volume
- 13
- Issue
- 2
- Pages
- 72-78
- ISSN
- 1527-4160 (ISSN-L)
- 1538-1145
- OpenAlex
- W1995696853
- Cited by
- 140
- References
- 12
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacologic Reduction of CNS Noradrenergic Activity in PTSD: The Case for Clonidine and Prazosin. https://app.cochat.ai/papers/10.1097/01.pra.0000265763.79753.c1
- The paper
- BOEHNLEIN, J. K., & KINZIE, J. D. (2007). Pharmacologic Reduction of CNS Noradrenergic Activity in PTSD: The Case for Clonidine and Prazosin. Journal of Psychiatric Practice. https://doi.org/10.1097/01.pra.0000265763.79753.c1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.